Company: SVREW
Filing Date: 2025-04-03
Form Type: 424B3
Source: 0001213900-25-028398
Chunk: 0

Company: SaverOne 2014 Ltd.
Filing Date: 2025-04-03
Form: 424B3
Chunk 0
---
| PROSPECTUS |     | Filed                      
 Pursuant to Rule 424(b)(3) 
 Registration               
 No. 333-286266             |

<div align='center'>Up to 404,537,940 Ordinary Shares
Represented by 337,200 American Depositary Shares

SaverOne 2014 Ltd.</div>

This prospectus relates to the offer and sale from time to time, by the selling shareholders identified in this prospectus under the caption “Selling Shareholders,” each the “Selling Shareholder” and collectively, the “Selling Shareholders”), of up to 404,537,940 ordinary shares, par value NIS 0.01 per share (the “Ordinary Shares”) of SaverOne 2014 Ltd. (“SaverOne” or the “Company”) represented by 337,200 American Depositary Shares (“ADS”). The Ordinary Shares include (i) up to 390,857,940 Ordinary Shares represented by 325,797 ADSs issuable upon exercise of purchase warrants at an exercise price of $10.664 per ADS (the “Investor Warrants”) issued to certain Selling Shareholders that purchased Investor Warrants in the Company’s private placement offering (the “Private Placement Offering”) pursuant to the purchase agreements dated January 30, 2025 (the “Purchase Agreements”); and (ii) 13,680,000 Ordinary Shares represented by 11,403 ADSs issuable upon exercise of purchase warrants at an exercise price of $11.66375 per ADS (the “Placement Agent Warrants”) issued to designees of the Placement Agent (as defined below) in connection with the Private Placement Offering and a concurrent registered public offering. See the section titled “ The January 2025 Offering” below for a description of the Private Placement Offering and the issuance of Investor Warrants and the Placement Agent Warrants pursuant to the Purchase Agreement.

We are not selling any Ordinary shares or ADSs under this prospectus and will not receive any proceeds from the sale of ADSs by the Selling Shareholders. We may receive proceeds from any cash exercise of Investor Warrants and the Placement Agent Warrants (up to a maximum of $3,607,300); however, we cannot predict when and in what number Investor Warrants will be exercised, if any. If Investor Warrants expire or exercised by cashless exercise (available only if there is no effective registration statement that registered for the resale of all of the Ordinary Shares issuable upon exercise of